Did you know?

Spectrum Pharmaceuticals last reported its quarterly earnings results on May 9th, unveiling an impressive performance that surpassed analysts’ expectations. Despite experiencing a loss of ($0.02) per share for the quarter, it exceeded consensus estimates by $0.03, indicating strong underlying fundamentals within the company.Spectrum Pharmaceuticals (SPPI) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to loss of $0.09 per share a year ago.05/10/2023 Third Quarter 2023 Financial Results 11/08/2023 Second Quarter 2023 Financial Results 08/03/2023 Annual Meeting of Stockholders 05/10/2023 Latest Presentation Quarterly Results Q3 2023 Earnings Release View All Results

Spectrum Pharmaceuticals (NASDAQ:SPPI) stock is soaring after an all-stock acquisition deal with Assertio Holdings was announced Tuesday morning. The $248 million purchase price values Spectrum shares at $1.14 each, a significant premium over its Tuesday closing price of $0.69. The stock price surged more than 30% to $0.90 Tuesday morning.More than 250 Spectrum Chemical employees work together across three worldwide locations. We offer more than 45,000 chemicals in laboratory, scale-up and bulk quantities, as well as more than 60,000 supplies, equipment and PPE consumables. In all, we represent 250 manufacturers and serve 120 industries in 70 countries.It also withdrew its outlook for the full year of 2023! Assertio (NASDAQ: ASRT) stock is falling hard on Friday after the pharmaceutical company released its second-quarter earnings report ...Apr 26, 2023 ... The upcoming acquisition of Spectrum Pharmaceuticals ... Assertio said on Tuesday that it would acquire all of the outstanding shares of Spectrum.

Mar 6, 2023 · Spectrum Pharmaceuticals develops and commercializes cancer therapies, including Rolvedon. Read more to see why SPPI stock is a Sell. If you’re on a Spectrum internet plan, there are some things you can do to get the most out of it. Spectrum offers a variety of plans, each with its own unique set of benefits and disadvantages. ….

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Spectrum pharma stock. Possible cause: Not clear spectrum pharma stock.

Spectrum Stockholders Will Receive Upfront Consideration of 0.1783 ASRT shares per SPPI Share ($1.14 per share) Plus One CVR for Total Potential Consideration of up to $1.34 per Share Upfront...April 25, 2023 at 1:03 PM · 1 min read. Assertio Holdings Inc (NASDAQ: ASRT) will acquire Spectrum Pharmaceuticals Inc (NASDAQ: SPPI) in an all-stock and contingent value rights (CVR)...Transaction Expected to Be Accretive to Assertio’s Adjusted EPS and Operating Cash Flow in 2024. Spectrum Stockholders Will Receive Upfront Consideration of 0.1783 ASRT shares per SPPI Share ($1...

The Spectrum Pharmaceuticals class action lawsuit (Luo v. Spectrum Pharmaceuticals, Inc. Spectrum Pharmaceuticals, Inc. , No. 2:21-cv-01612) was commenced on August 31, 2021 in the District of Nevada.Spectrum Pharmaceuticals GAAP EPS of -$0.02 beats by $0.03, revenue of $15.6M beats by $1.44M Seeking Alpha 182d Spectrum Pharmaceuticals (SPPI) Receives a Hold from JMP Securities

pre market trading hours That deal values SPPI stock at $1.34 per share, which is a 94% premium over the stock’s closing price on Monday. It also brings the total value of the deal to $291 million. When the deal closes ... one month t bill rateamazon stock price historical Aug 6, 2021 · Get the latest Spectrum Pharmaceuticals Inc. (SPPI) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI) ('Spectrum' or the 'Company'), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced that the Company has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding Spectrum's New Drug Application (NDA) for poziotinib for the treatment of patients with previously ... national.fuel Shares of small-cap drug maker Spectrum Pharmaceuticals ... Fintel’s consensus forecast price target of $3.16 suggests the stock could see a further 350% upside over 2022. The chart provided ... safest forex brokerapextradingfundingwhat is parlay in sports betting The biological spectrum consists of all living organisms divided into three domains, coexisting across various levels of biological organization. Microbiologist Carl Woese organized all known organisms into a phylogenetic tree of life based... california workers compensation insurance companies SPECTRUM PHARMACEUTICALS, INC. COMMON STOCK Our common stock is traded on the Nasdaq SmallCap Market under the symbol “SPPI.” On September 8, 2003, the closing price of our common stock was $5.10. This prospectus relates to the sale of up to 1,270,429 shares of our common stock by the selling stockholders named in this prospectus. Under the terms of the agreement, at closing, Spectrum stockholders will receive a fixed exchange ratio of 0.1783 shares of Assertio common stock for each share of Spectrum common stock they own ... nyse mainpublic solar power companiesequity trust reviews Spectrum Pharmaceuticals Inc: ASRT: Assertio Holdings Inc: Jul 31, 2023: UNVR: Univar Solutions Inc: APO: Apollo Global Management Inc: Jul 27, 2023: AJRD: Aerojet Rocketdyne Holdings Inc: LHX: L3harris Technologies Inc: Jul 26, 2023: ABST: Absolute Software Corp-Crosspoint Capital Partners Lp: Jul 21, 2023: GRNA: Greenlight …Spectrum Pharmaceuticals press release (SPPI): Q4 GAAP EPS of -$0.06 beats by $0.05.Revenue of $10.1M beats by $0.3M.Cash, cash equivalents and marketable securities of $75.1 million...